Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5–11 years: Author’s reply to correspondence

Dear Editor, We would like to reply to “Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5–11years: Correspondence” regarding our article entitled “Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNTech) vaccine in children aged 5–11years: Results from an active pharmacovigilan...

Descripción completa

Detalles Bibliográficos
Autores principales: Ripabelli, Giancarlo, Salzo, Angelo, Tamburro, Manuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Coronavirus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980581/
https://www.ncbi.nlm.nih.gov/pubmed/36655383
http://dx.doi.org/10.1080/21645515.2023.2168947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980581/
https://www.ncbi.nlm.nih.gov/pubmed/36655383
http://dx.doi.org/10.1080/21645515.2023.2168947

Ejemplares similares